Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities:
Net loss	$ (671,933)	$ (916,506)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	384,633	549,641
Amortization of deferred financing cost	115,644	75,798
Provision for bad debt	17,211	(4,943)
Fair value of options and warrants	433,404	803,383
Non-cash expenses paid on company's behalf		204,920
Loss (gain) on sale of fixed assets	902	(448)
Changes in operating assets and liabilities:
Accounts receivable	29,968	(153,622)
Prepaid expenses and other assets	(365,332)	(245,521)
Restricted cash		(500,000)
Accounts payable and accrued expenses	(753,229)	(365,461)
Deferred revenues	37,767	(7,500)
Other assets	(3,582)	8,076
Net cash used in operating activities	(774,547)	(552,183)
Cash flows from investing activities:
Capitalized software for internal use	(891,393)	(1,030,456)
Capital expenditures	(32,980)	(7,585)
Proceeds from sale of assets	795	5,642
Net cash used in investing activities	(923,578)	(1,032,399)
Cash flows from financing activities:
Principal repayments of credit facility and loan	(1,030,837)	(87,777)
Proceeds from credit facility	1,150,000	1,803,105
Payment of financing costs		(129,678)
Net cash provided by financing activities	119,163	1,585,650
Effect of exchange rate changes on cash	19,257	(29,497)
Net decrease in cash	(1,559,705)	(28,429)
Cash, beginning of period	1,680,127	908,095
Cash, end of period	120,422	879,666
Supplemental disclosures of cash flow information:
Cash paid for interest	395,545	419,802
Cash paid for income taxes	0	0
Non-cash investing and financing activities:
Fair value of warrants issued in connection with line of credit		391,618
Principal loan payments included in accounts payable	25,000	25,000
Repayment of line of credit		4,572,223
Capital expenditure included in accounts payable	7,282
Shares issued for cashless exercise of options and warrants	$ 1,868